Diabetes, Digestive, and Kidney Diseases Extramural Research in Connecticut
CFDA 93.847 — federal program obligations to Connecticut
Total obligated
$493.2M
Awards
208
Diabetes, Digestive, And Kidney Diseases Extramural Research (CFDA 93.847) shows $472,317,143.46 in USAspending.gov obligations with Connecticut as place of performance. Two hundred awards carry that total. The join is an HHS research listing crossed with a state location field, not Connecticut's entire budget and not a census of Connecticut diabetes patients or unique investigators. The dollars are commitments, not Treasury outlays.
Key figures
- CFDA 93.847 in Connecticut shows $472,317,143.46 in USAspending obligations on two hundred awards.
- Award rows are 93.847 actions, not patients or unique PIs.
- The join is CFDA 93.847 plus Connecticut place of performance, not 93.855 allergy dollars.
- The total is commitments, not outlays already paid.
Connecticut × 93.847 is diabetes-kidney research, not a patient census
This page pairs CFDA 93.847, DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH, with Connecticut place of performance. Diabetes, Digestive, And Kidney Diseases Extramural Research, as named on the catalog line, is the listing on one side of the join; Connecticut (CT) is the geography tag on the other. SpendingVault sums tagged obligations: $472,317,143.46 on 200 awards. The extract does not list trial enrollments, New Haven shares, or a diabetes-versus-kidney split. Treat the pair as a catalog intersection, not a ranking of which state needs the program more, and not a claim that 200 awards equal that many Connecticut research campuses. Connecticut (CT) excludes New York, Massachusetts, and Rhode Island. Yale folklore is not a campus extract. Place of performance is CT statewide.
Other listings — allergy-and-infectious-disease research on 93.855 or other 93-series research rows — sit outside $472,317,143.46 unless they also carry 93.847. Mixing Diabetes research with those rows would invent a combined figure the packet never computed. Correlation between this obligation sum and obesity rates is not causation. Those statistics are not in the packet. Place of performance as Connecticut locates the tagged awards; it does not deposit $472,317,143.46 in the state treasury, and it does not prove every dollar stayed inside Connecticut after subawards. medical-school folklore is not a published cut of this extract.
200 awards behind the Connecticut 93.847 total
Award count is a row count of assistance awards, including possible continuations and modifications. It is not a census of Connecticut diabetes patients or unique investigators. a research file of two hundred award rows, not a formula lump. Mean obligation is about $2.36 million if $472,317,143.46 were divided evenly across two hundred lines — a mechanical ratio, not a typical payment published by the agency.
The listing names diabetes, digestive, and kidney diseases together. This packet does not split $472,317,143.46 among those three disease groups. Two hundred awards stay on 93.847 × CT. The 93.855 allergy cell is a different CFDA. Two hundred awards are scannable on the overlay. This page will not invent recipient names. Open Diabetes, Digestive, And Kidney Diseases Extramural Research in Connecticut for the stored table. Do not convert 200 into a map of Connecticut research campuses. The $472,317,143.46 total remains an obligation rollup on tagged awards.
Questions
- How much Diabetes research is obligated in Connecticut?
- USAspending.gov shows $472,317,143.46 in obligations for CFDA 93.847 with Connecticut as place of performance, across two hundred awards. The sum is a commitment total on assistance awards, not outlays and not the state's entire federal-spending total. Other listings are outside this join unless they also carry 93.847.
- Do 200 awards mean 200 Connecticut diabetes studies?
- No. Award count is a row count of assistance awards and can include continuations. It is not a census of Connecticut diabetes patients or unique investigators. The packet does not name recipients. See Diabetes, Digestive, And Kidney Diseases Extramural Research in Connecticut for named lines as USAspending stored them. Unique Connecticut research campuses are unpublished.
- Does this total include Connecticut allergy research on 93.855?
- No. The join is CFDA 93.847 crossed with Connecticut place of performance. Related programs on other CFDA numbers are not inside $472,317,143.46 unless the award also carries 93.847. allergy-and-infectious-disease research on 93.855 or other 93-series research rows. Mixing those rows would invent a combined figure the packet never computed.
- Is the Diabetes research total already paid in Connecticut?
- Not on this metric. Obligations are recorded commitments on assistance awards. Outlays are payments from the Treasury. The $472,317,143.46 headline is the obligation rollup in SpendingVault's extract. Completed activity and remaining balances are not published in this packet.
USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.
How this pair fits
Explore related views: National Diabetes, Digestive, and Kidney Diseases Extramural Research profile · All programs in Connecticut · All spending in Connecticut